News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Industry News First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate) July 29, 2015
Presentation Economic Analysis of Ticagrelor TherapyFrom a US Perspective Presenter: Patricia A. Cowper February 02, 2015
News Daily News Long-term Ticagrelor Therapy Cost-Effective in US Patients L.A. McKeown February 02, 2015
Presentation TCT 2014 No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred! Presenter: Dirk Sibbing September 14, 2014
News Daily News El Estatus del VIH No Influye en la Eficacia de las PCI Yael L. Maxwell July 07, 2014